BlackRock Health Sciences Trust (NYSE:BME – Get Free Report) was the target of a significant increase in short interest in the month of September. As of September 30th, there was short interest totalling 4,900 shares, an increase of 122.7% from the September 15th total of 2,200 shares. Based on an average trading volume of 28,600 shares, the short-interest ratio is currently 0.2 days.
Institutional Inflows and Outflows
Hedge funds have recently modified their holdings of the company. HBK Sorce Advisory LLC increased its stake in BlackRock Health Sciences Trust by 14.4% in the 1st quarter. HBK Sorce Advisory LLC now owns 7,009 shares of the company’s stock valued at $290,000 after buying an additional 884 shares during the last quarter. Calamos Advisors LLC increased its position in shares of BlackRock Health Sciences Trust by 46.4% in the second quarter. Calamos Advisors LLC now owns 7,884 shares of the company’s stock valued at $322,000 after acquiring an additional 2,500 shares during the last quarter. City of London Investment Management Co. Ltd. bought a new stake in BlackRock Health Sciences Trust during the second quarter worth about $429,000. Logan Stone Capital LLC acquired a new position in BlackRock Health Sciences Trust during the second quarter valued at approximately $600,000. Finally, Raymond James Trust N.A. grew its stake in BlackRock Health Sciences Trust by 8.1% in the second quarter. Raymond James Trust N.A. now owns 22,036 shares of the company’s stock valued at $900,000 after purchasing an additional 1,649 shares in the last quarter.
BlackRock Health Sciences Trust Trading Up 0.6 %
BME traded up $0.23 during trading on Friday, hitting $41.88. The company had a trading volume of 26,396 shares, compared to its average volume of 31,688. The firm’s 50-day moving average price is $41.70 and its 200 day moving average price is $40.74. BlackRock Health Sciences Trust has a one year low of $35.53 and a one year high of $42.86.
BlackRock Health Sciences Trust Dividend Announcement
BlackRock Health Sciences Trust Company Profile
BlackRock Health Sciences Trust is a closed-ended equity mutual fund launched by BlackRock, Inc The fund is managed by BlackRock Advisors, LLC. It invests in the public equity markets of the United States. The fund seeks to invest in stocks of companies operating in the health sciences and related sectors, which include businesses involved in researching, developing, producing, distributing or delivering medical, dental, optical, pharmaceutical or biotechnology products, supplies, equipment, or services.
Read More
- Five stocks we like better than BlackRock Health Sciences Trust
- 2 Fintech Stocks to Buy Now and 1 to Avoid
- Why Fastenal Stock Could Hit New Highs After Strong Q3 Results
- What is a Death Cross in Stocks?
- Why Eli Lilly Stock Is Soaring—and How It Plans to Stay on Top
- Using the MarketBeat Dividend Yield Calculator
- 3 Mid-Cap Stocks Under $20 With Insider Buying and Major Upside
Receive News & Ratings for BlackRock Health Sciences Trust Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BlackRock Health Sciences Trust and related companies with MarketBeat.com's FREE daily email newsletter.